Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Kaival Brands Innovations Group (KAVL) Announces Proposed Public Offering of Common Stock and Warrants
-
Kaival Brands Announces Proposed Public Offering of Common Stock and Warrants
-
UPDATE: Maxim Group Starts SPI Energy Co Ltd. (SPI) at Buy
-
WISeKey Increases Investment on its NFT Platform by Accessing the Remainder of its $44 Million Convertible Notes Subscription Agreements Signed middle of the Year
-
WISeKey Increases Investment on its NFT Platform by Accessing the Remainder of its $44 Million Convertible Notes Subscription Agreements Signed middle of the Year
-
Dynatronics (DYNT) PT Raised to $3 at Maxim Group, Following Earnings
-
Xeriant, Inc. (XERI) and XTI Aircraft to Merge
-
Xeriant and XTI Aircraft sign LOI to pursue Merger
-
M-Vest and Maxim Group LLC to Host the Advances in Mental Health Virtual Conference on Wednesday September 22, 2021 at 9 a.m. EDT
-
MindMed Announces Participation at Upcoming Investor Conferences
-
Awakn Life Sciences to Present at the Oppenheimer and Maxim Group September Investor Conferences
-
Nuwellis, Inc. Announces Closing of $10.0 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option
-
BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Exec to Participate in Upcoming in Mental Health Virtual Conference
-
Maxim Group Reiterates Buy Rating on Digital Turbine (APPS) Following CEO Meeting
-
MINDCURE to Participate in Maxim Group LLC's Advances in Mental Health Virtual Conference
-
UPDATE: Maxim Group Starts Auddia (AUUD) at Buy
-
Adial CEO William Stilley Invited to Participate in Maxim Group’s Virtual Panel Series Conference: “Disruptors in the Mental Health Space”
-
Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
-
Nuwellis (NUWE) Prices 3.48M Share Offering at $2.50/sh
-
Nuwellis, Inc. Announces Pricing of $8.7 Million Underwritten Public Offering of Common Stock
-
UPDATE: Maxim Group Starts 180 Life Sciences Corp. (ATNF) at Buy
-
UPDATE: Maxim Group Starts Unisys (UIS) at Buy
-
Achieve Life Sciences to Participate in Upcoming Investor Conferences
-
Modiv Inc. Prices Upsized Public Offering of 1,800,000 Shares of 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock
-
Modiv Inc. Prices Upsized Public Offering of 1,800,000 Shares of 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock
-
Lobe Sciences Provides Corporate Update to Investors and Stakeholders
-
Modiv Inc. Announces Offering of Series A Cumulative Redeemable Perpetual Preferred Stock
-
Modiv Inc. Announces Offering of Series A Cumulative Redeemable Perpetual Preferred Stock
-
Inpixon (INPX) Announces Pricing of $54.1M Registered Direct Offering of Convertible Preferred Stock and Warrants to Acquire Common Stock at Per Share Price of $1.25
-
Inpixon Announces Pricing of $54.1 Million Registered Direct Offering of Convertible Preferred Stock and Warrants to Acquire Common Stock at a Per Share Price of $1.25
-
Field Trip Health Ltd. to Participate in Four Investor Conferences in September
-
Small Pharma to Present at Upcoming September Investor Conferences
-
Small Pharma to Present at Upcoming September Investor Conferences
-
Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies
-
Hello Pal Engages Maxim Group LLC for Potential NASDAQ Listing and Advisory and Investment Banking Services
-
Seelos Therapeutics to Participate in Two Investor Conferences in September
-
Sphere 3D Corp. Announces Closing of Previously Announced $192.1 Million Registered Direct Offering Priced At-the-Market
-
Sphere 3D (ANY) Prices $192.1M Share and Warrant Offering at $8.50/sh
-
Sphere 3D Announces Pricing of $192.1 Million Registered Direct Offering Priced At-the-Market to Help Secure the Initial Order of 60,000 Miners
-
Alpine Acquisition Corporation Announces Closing of $107.0 Million Initial Public Offering, Including Partial Exercise of the Overallotment Option
-
Alpine Acquisition Corporation Announces Closing of $107.0 Million Initial Public Offering, Including Partial Exercise of the Overallotment Option
-
Worksport Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Underwritten Public Offering
-
Worksport Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Underwritten Public Offering
-
SeqLL Inc. Announces Closing of Upsized $13 Million Initial Public Offering
-
SeqLL Inc. Announces Closing of Upsized $13 Million Initial Public Offering
-
IPO for SPAC Alpine Acquisition Corporation (REVE) Opens at $10.03
-
Minority Equality Opportunities Acquisition Inc. Becomes the First Minority-Led SPAC Traded on NASDAQ, Closes $126.5 million IPO
-
UPDATE: Maxim Group Starts Palisade Bio Inc. (PALI) at Buy, $7 PT
-
Alpine Acquisition Corporation (REVEU) Prices 10M Unit IPO at $10/unit
-
Alpine Acquisition Corporation Announces Pricing of $100.0 Million Initial Public Offering
